Welcome to GoldFish Pharma
GoldFish Pharma. At Global level, the Pharma industry is passing through the changeover situation and new strategic alliances, mergers and takeovers are taking place by identifying the strength of each company and joining hands to fully utilise the opportunities to sustain the growth rate in the next century. During this process, the year 2008 AD is an important milestone year for the Indian Pharmaceutical Industry.
Patents of around 200 Bulk Active ingredients are due to expire during the coming years and would be coming out of the Patent Law. This would open-up new markets for these products. The excellent opportunity area is supply of Bulk Pharmaceutical industry which include APIs(Active Pharmaceutical Industry), drug intermediates and its chemicals, and along with finished dosage forms, primarily for global generic markets. This market is estimated to be worth around US $ 100 billion and growing at a double digit percentage (as this is directly related to growth in human population growth rate). The USA and the Western Europe are the predominent markets.
Our Therapeutic segment ranges from
- Gastro - Protection and Gastro-Retention Products
- Anti - Infective Products
- Anti - Pain or Pain Management Products
- Anti Obesity Products
- Taste Masking Products
- Immune Suppressants
Products protected by valid patents are not offered for sale in countries,where the sale of such products constitutes a patent infringement.
The liability for any patent infringement is the responsibility of the buyer/customer.